KIF13A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.013000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.197000E-01
Normal-vs-Stage2
5.236800E-01
Normal-vs-Stage3
9.348600E-01
Normal-vs-Stage4
1.672230E-02
Stage1-vs-Stage2
6.773400E-01
Stage1-vs-Stage3
4.112200E-01
Stage1-vs-Stage4
4.206100E-02
Stage2-vs-Stage3
5.183200E-01
Stage2-vs-Stage4
1.780260E-03
Stage3-vs-Stage4
1.109910E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.229400E-01
Normal-vs-AfricanAmerican
4.728600E-01
Normal-vs-Asian
5.810000E-01
Caucasian-vs-AfricanAmerican
7.677200E-01
Caucasian-vs-Asian
7.823800E-01
AfricanAmerican-vs-Asian
9.566000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.826400E-01
Normal-vs-Female
4.074200E-01
Male-vs-Female
3.731000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.875200E-01
Normal-vs-Age(41-60Yrs)
3.182000E-01
Normal-vs-Age(61-80Yrs)
6.056600E-01
Normal-vs-Age(81-100Yrs)
5.572600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.396200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.981000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.394400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.275000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.573400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.823400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.306800E-01
Normal-vs-Daily Drinker
9.233200E-01
Normal-vs-Weekly Drinker
4.488600E-01
Normal-vs-Occasional Drinker
3.457800E-01
Normal-vs-Social Drinker
3.756800E-01
Non Drinker-vs-Daily Drinker
6.912200E-01
Non Drinker-vs-Weekly Drinker
1.086240E-01
Non Drinker-vs-Occasional Drinker
4.488500E-02
Non Drinker-vs-Social Drinker
7.613900E-02
Daily Drinker-vs-Weekly Drinker
1.147030E-01
Daily Drinker-vs-Occasional Drinker
2.944400E-02
Daily Drinker-vs-Social Drinker
3.993800E-02
Weekly Drinker-vs-Occasional Drinker
5.434200E-01
Weekly Drinker-vs-Social Drinker
5.450800E-01
Occasional Drinker-vs-Social Drinker
9.615600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.824240E-01
Normal-vs-Grade 2
3.796000E-02
Normal-vs-Grade 3
4.134300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.296970E-01
Grade 1-vs-Grade 3
2.076600E-01
Grade 1-vs-Grade 4
1.824240E-01
Grade 2-vs-Grade 3
9.164400E-01
Grade 2-vs-Grade 4
3.796000E-02
Grade 3-vs-Grade 4
4.134300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.653200E-01
Normal-vs-NonDiabetic
5.331200E-01
Diabetic-vs-NonDiabetic
8.469600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.672600E-01
Normal-vs-NoPancreatitis
5.384400E-01
Pancreatitis-vs-NoPancreatitis
7.028800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.381400E-01
Normal-vs-N1
5.059000E-01
N0-vs-N1
8.825200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.484600E-01
Normal-vs-TP53-NonMutant
4.618200E-01
TP53-Mutant-vs-TP53-NonMutant
5.949000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
